NEW YORK, March 9 – A Japanese tumorogenesis researcher arrived in New York on Wednesday to begin a mouse microarray project at Memorial Sloan-Kettering's Ludwig Center for Cancer Research only to find out that defects in the Affymetrix U74 mouse microarrays had stopped the project dead in its tracks. 

“That whole plan has been six months in the making,” said Michael Marino, a researcher at the Ludwig Institute. “Today we find we can’t go ahead with the research – it’s just wasting time.”

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.